<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02355548</url>
  </required_header>
  <id_info>
    <org_study_id>1018558</org_study_id>
    <nct_id>NCT02355548</nct_id>
  </id_info>
  <brief_title>Outpatient Treatment of Low-risk Pulmonary Embolism</brief_title>
  <acronym>Low Risk PE</acronym>
  <official_title>Rapid Risk Stratification for Outpatient Treatment of Low-risk Pulmonary Embolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intermountain Health Care, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intermountain Health Care, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is looking at the safety and effectiveness of treating Patients diagnosed with a
      low-risk Pulmonary Embolism (PE) in an outpatient setting instead of the standard, in-patient
      hospitalization. Patients have several medical tests done during their Emergency Department
      visit. Based on those tests, those who are determined to have a low-risk PE are eligible to
      participate in the study. Those choosing to participate are discharged after 12 hours of
      medical observation. Patients who choose to participate are followed up by telephone
      approximately 90 days later.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>90-day all-cause mortality, recurrent VTE, and Major Bleeding during outpatient treatment of Low-risk PE</measure>
    <time_frame>90 Days</time_frame>
    <description>This is a composite outcome of the above.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction of medical costs due to outpatient treatment.</measure>
    <time_frame>90 Days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of patient satisfaction as measured by survey.</measure>
    <time_frame>90 Days Post study enrollment</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Pulmonary Embolism</condition>
  <arm_group>
    <arm_group_label>Outpatient Treatment</arm_group_label>
    <description>All patients eligible for the study will have their PE treated in the outpatient setting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Outpatient Treatment of Pulmonary Embolism</intervention_name>
    <description>Patients who participate in the study will be treated for their pulmonary embolism in an outpatient setting instead of being hospitalized.</description>
    <arm_group_label>Outpatient Treatment</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The subject population is drawn from patients arriving in the Emergency Department who are
        then diagnosed with a lower risk pulmonary embolism (PESI score &lt;86).
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Pulmonary Embolism, diagnosed by CTA or high probability VQ Scan

          2. Total Pulmonary Embolism Severity Index (PESI) score &lt;86

        Exclusion Criteria:

          1. Massive Pulmonary Embolism: Hypotension with signs of right heart strain on CTA or
             Echocardiogram

          2. Sustained Systolic Blood Pressure (SBP) &lt;95 mmHg during Emergency Department or
             observation stay.

          3. Age &lt;18

          4. Pregnant

          5. Renal insufficiency (Creatinine Clearance &lt;30)

          6. Hepatic Dysfunction (AST/ALT/ALP &gt; 3 times upper limit of normal)

          7. Unreliable social situation or inability to follow up

          8. Contraindication to enoxaparin, warfarin and rivaroxaban

          9. Atrial or ventricular dysrhythmia(s)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joseph Bledsoe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Intermountain Health Care, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Intermountain Medical Center</name>
      <address>
        <city>Murray</city>
        <state>Utah</state>
        <zip>84157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005 Oct 15;172(8):1041-6. Epub 2005 Jul 14.</citation>
    <PMID>16020800</PMID>
  </reference>
  <reference>
    <citation>Aujesky D, Roy PM, Le Manach CP, Verschuren F, Meyer G, Obrosky DS, Stone RA, Cornuz J, Fine MJ. Validation of a model to predict adverse outcomes in patients with pulmonary embolism. Eur Heart J. 2006 Feb;27(4):476-81. Epub 2005 Oct 5.</citation>
    <PMID>16207738</PMID>
  </reference>
  <reference>
    <citation>Jiménez D, Yusen RD, Otero R, Uresandi F, Nauffal D, Laserna E, Conget F, Oribe M, Cabezudo MA, Díaz G. Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest. 2007 Jul;132(1):24-30.</citation>
    <PMID>17625081</PMID>
  </reference>
  <reference>
    <citation>Squizzato A, Ageno W. The 8(th) American College of Chest Physicians Guidelines - a perspective on venous thromboembolism guidelines. Thromb Haemost. 2009 Jan;101(1):31-5. Review.</citation>
    <PMID>19132186</PMID>
  </reference>
  <reference>
    <citation>Janjua M, Badshah A, Matta F, Danescu LG, Yaekoub AY, Stein PD. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review. Thromb Haemost. 2008 Nov;100(5):756-61. Review.</citation>
    <PMID>18989517</PMID>
  </reference>
  <reference>
    <citation>Betriu A, Califf RM, Bosch X, Guerci A, Stebbins AL, Barbagelata NA, Aylward PE, Vahanian A, Van de Werf F, Topol EJ. Recurrent ischemia after thrombolysis: importance of associated clinical findings. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA [tissue-plasminogen activator] for Occluded Coronary Arteries. J Am Coll Cardiol. 1998 Jan;31(1):94-102.</citation>
    <PMID>9426024</PMID>
  </reference>
  <reference>
    <citation>Koopman MM, Prandoni P, Piovella F, Ockelford PA, Brandjes DP, van der Meer J, Gallus AS, Simonneau G, Chesterman CH, Prins MH. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med. 1996 Mar 14;334(11):682-7. Erratum in: N Engl J Med 1997 Oct 23;337(17):1251.</citation>
    <PMID>8594426</PMID>
  </reference>
  <reference>
    <citation>Ageno W, Steidl L, Marchesi C, Dentali F, Mera V, Squizzato A, Crowther MA, Venco A. Selecting patients for home treatment of deep vein thrombosis: the problem of cancer. Haematologica. 2002 Mar;87(3):286-91.</citation>
    <PMID>11869941</PMID>
  </reference>
  <reference>
    <citation>Agnelli G, Verso M, Ageno W, Imberti D, Moia M, Palareti G, Rossi R, Pistelli R; MASTER investigators. The MASTER registry on venous thromboembolism: description of the study cohort. Thromb Res. 2008;121(5):605-10. Epub 2007 Aug 10.</citation>
    <PMID>17692901</PMID>
  </reference>
  <reference>
    <citation>Wells PS, Kovacs MJ, Bormanis J, Forgie MA, Goudie D, Morrow B, Kovacs J. Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection. Arch Intern Med. 1998 Sep 14;158(16):1809-12.</citation>
    <PMID>9738611</PMID>
  </reference>
  <reference>
    <citation>Wicki J, Perrier A, Perneger TV, Bounameaux H, Junod AF. Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost. 2000 Oct;84(4):548-52.</citation>
    <PMID>11057848</PMID>
  </reference>
  <reference>
    <citation>Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, Roy PM, Fine MJ. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med. 2006 Jan 23;166(2):169-75.</citation>
    <PMID>16432084</PMID>
  </reference>
  <reference>
    <citation>Brillman J, Mathers-Dunbar L, Graff L, Joseph T, Leikin JB, Schultz C, Severance HW Jr, Werne C. Management of observation units. American College of Emergency Physicians. Ann Emerg Med. 1995 Jun;25(6):823-30.</citation>
    <PMID>7755208</PMID>
  </reference>
  <reference>
    <citation>Cross E, How S, Goodacre S. Development of acute chest pain services in the UK. Emerg Med J. 2007 Feb;24(2):100-2.</citation>
    <PMID>17251613</PMID>
  </reference>
  <reference>
    <citation>Daly S, Campbell DA, Cameron PA. Short-stay units and observation medicine: a systematic review. Med J Aust. 2003 Jun 2;178(11):559-63. Review.</citation>
    <PMID>12765504</PMID>
  </reference>
  <reference>
    <citation>Martinez E, Reilly BM, Evans AT, Roberts RR. The observation unit: a new interface between inpatient and outpatient care. Am J Med. 2001 Mar;110(4):274-7.</citation>
    <PMID>11239845</PMID>
  </reference>
  <reference>
    <citation>Roberts R, Graff LG 4th. Economic issues in observation unit medicine. Emerg Med Clin North Am. 2001 Feb;19(1):19-33. Review.</citation>
    <PMID>11214399</PMID>
  </reference>
  <reference>
    <citation>Goodacre SW. Should we establish chest pain observation units in the UK? A systematic review and critical appraisal of the literature. J Accid Emerg Med. 2000 Jan;17(1):1-6. Review.</citation>
    <PMID>10658981</PMID>
  </reference>
  <reference>
    <citation>Farkouh ME, Smars PA, Reeder GS, Zinsmeister AR, Evans RW, Meloy TD, Kopecky SL, Allen M, Allison TG, Gibbons RJ, Gabriel SE. A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med. 1998 Dec 24;339(26):1882-8.</citation>
    <PMID>9862943</PMID>
  </reference>
  <reference>
    <citation>Crenshaw LA, Lindsell CJ, Storrow AB, Lyons MS. An evaluation of emergency physician selection of observation unit patients. Am J Emerg Med. 2006 May;24(3):271-9.</citation>
    <PMID>16635696</PMID>
  </reference>
  <reference>
    <citation>Wilkinson K, Severance H. Identification of chest pain patients appropriate for an emergency department observation unit. Emerg Med Clin North Am. 2001 Feb;19(1):35-66. Review.</citation>
    <PMID>11214403</PMID>
  </reference>
  <reference>
    <citation>Dalen JE. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest. 2002 Oct;122(4):1440-56. Review.</citation>
    <PMID>12377877</PMID>
  </reference>
  <reference>
    <citation>Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation. 2003 Dec 2;108(22):2726-9. Review.</citation>
    <PMID>14656907</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>January 30, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2015</study_first_posted>
  <last_update_submitted>August 28, 2017</last_update_submitted>
  <last_update_submitted_qc>August 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Pulmonary Embolism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

